Latest Insider Transactions at Caladrius Biosciences, Inc. (CLBS)
This section provides a real-time view of insider transactions for Caladrius Biosciences, Inc. (CLBS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CALADRIUS BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CALADRIUS BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2022
|
Steven S Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+23.56%
|
-
|
|
Jan 10
2022
|
Peter G Traber Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+30.49%
|
-
|
|
Jan 10
2022
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
65,430
+26.38%
|
-
|
|
Jan 10
2022
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,694
-2.35%
|
$0
$0.92 P/Share
|
|
Jan 10
2022
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
64,500
+16.48%
|
-
|
|
Jan 10
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
SELL
Payment of exercise price or tax liability
|
Direct |
17,405
-9.27%
|
$0
$0.92 P/Share
|
|
Jan 10
2022
|
Todd C Girolamo CLO, SVP of Corp Dev |
BUY
Grant, award, or other acquisition
|
Direct |
129,000
+40.74%
|
-
|
|
Jan 10
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
56,410
-7.86%
|
$0
$0.92 P/Share
|
|
Jan 10
2022
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
401,000
+35.86%
|
-
|
|
Dec 08
2021
|
Steven S Myers Director |
BUY
Open market or private purchase
|
Direct |
33,785
+18.7%
|
$0
$0.89 P/Share
|
|
Sep 01
2021
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,103
-16.03%
|
$50,103
$1.28 P/Share
|
|
Sep 01
2021
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
312,500
+50.0%
|
-
|
|
Jan 14
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,936
-1.94%
|
$5,936
$1.56 P/Share
|
|
Jan 13
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,212
-4.3%
|
$28,212
$1.55 P/Share
|
|
Jan 13
2021
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+10.47%
|
-
|
|
Jan 11
2021
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+31.1%
|
-
|
|
Jan 11
2021
|
Michael H. Davidson Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+20.73%
|
-
|
|
Jan 11
2021
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+30.51%
|
-
|
|
Jan 11
2021
|
Steven S Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+25.03%
|
-
|
|
Jan 11
2021
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+31.94%
|
-
|
|
Jan 11
2021
|
Peter G Traber Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+31.06%
|
-
|
|
Jan 11
2021
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+24.35%
|
-
|
|
Jan 11
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,621
-5.34%
|
$16,621
$1.59 P/Share
|
|
Jan 11
2021
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
119,000
+27.66%
|
-
|
|
Jan 08
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,726
-2.4%
|
$4,726
$1.6 P/Share
|
|
Nov 01
2020
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
79,470
+50.0%
|
$79,470
$1.51 P/Share
|